Pashto Translation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale

There is a need for a culturally adapted screening tool to aid health care professionals or clinicians screen for the presence of neuropathic pain associated with spinal cord injuries in Pashtoon population. . Since Paraplegic center Hayatabad Peshawar is a reputable institute for spinal cord injury patients' rehabilitation in Khyber pakhtun khwa where most of Pashto speaking SCI patients are rehabilitated. While working there as a physical therapist I, my other colleagues and patients felt a need for a screening tool for pain in Pashto language .So I decided to a conduct a tool validation study. This study will help the clinicians to assess their patient's pain type easily through the Pashto version of LANSS pain scale in Pashtoon population and hence will help in timely management of the pain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Spinal Cord Injuries Central Nervous System Diseases Nervous System Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Spinal Cord Diseases Trauma, Nervous System Wounds and Injuries

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Paraplegic Center

Peshawar, KPK, Pakistan

About this study

The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale, a screening questionnaire for identifying patients with neuropathic pain, was developed to identify patients with neuropathic mechanisms dominating their pain experience. The original English version of the LANSS pain scale has been translated and validated in Turkish, Spanish, Swedish, Brazilian, Portuguese, and Chinese Mandarin languages. However, no neuropathic pain questionnaire including the LANSS has yet been established in Pasto language in Pakistan.

Although these screening tools are based on descriptors, their linguistic adaptation and validation into different languages are feasible and this ensures their reliability and validity in languages other than those in which they were initially developed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with traumatic spinal cord injury
Both Complete and Incomplete SCI patients
Patients having pain history after spinal cord injury
Patients having 3 or more than 3 months duration of SCI
SCI at or below thoracic spine

Exclusion criteria

Patients with other neurological disorders like multiple sclerosis, GBS, etc.
Congenital conditions, tumor etc.
Diabetic patients.

Treatment and study plan

Primary outcomes

Pashto version of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale

Time frame: 1 week

Pashto version of the LANSS will be developed through our study which will be same in contents to English version and will be applied on the spinal cord injury patients for validity and reliability in Pashtoon population.
Douleur Neuropathique 4 Questions (DN4) questionnaire

Time frame: 1 week

The DN4 questionnaire consists of a total of 10 items grouped in 4 sections . The first seven items are related to the quality of pain (burning, painful cold, electric shocks) and its association to abnormal sensations (tingling, pins and needles, numbness, itching). The other 3 items are related to neurological examination in the painful area (touch hypoesthesia, pinprick hypoesthesia, tactile allodynia). A score of 1 is given to each positive item and a score of 0 to each negative item. The total score is calculated as the sum of all 10 items, and the cut-off value for the diagnosis of neuropathic pain is a total score of 4/10.

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Pashto Translation, Validity and Reliability of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale in Spinal Cord Injuries

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Sep 28, 2021
Registry last updated: Apr 5, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed